Alternative Medicine Review - Hematological response to short-term oral cyanocobalamin therapy for the treatment of cobalamin deficiencies in elderly patients
June 1, 2006 -- OBJECTIVES: The aim of this trial was to demonstrate the efficacy of one month of oral cobalamin (vitamin B 12) therapy in elderly patients with...
Journal of AOAC International - Determination of vitamin [B.sub.12] in food products by liquid chromatography/UV detection with immunoaffinity extraction: single-laboratory validation
July 1, 2008 -- A fast and simple method to determine vitamin [B.sub.12] in foods is presented. The method allows, in addition to the determination of added...
Chain Drug Review - Alliance to promote CaloMist
February 4, 2008 -- ST. LOUIS -- Fleming Pharmaceuticals has established a strategic alliance with Hawthorn Pharmaceuticals Inc. to expand the sales reach of Fleming's...
Alternative Medicine Review - Vitamins and minerals: their role in nail health and disease
December 1, 2007 -- Vitamins and minerals: their role in nail health and disease. Scheinfeld N, Dahdah MJ, Scher R. J Drugs Dermato1 2007;6:782-787. Nail health and...
Journal of Drugs in Dermatology - Vitamins and minerals: their role in nail health and disease
August 1, 2007 -- Abstract Nail health and appearance are global concerns. We investigated the use of biotin vitamin E, alpha-tocopherol, vitamin C (ascorbic acid),...
Business Wire - Allergy Patients Treated with PreHistin Had Rise in Ragweed IgE Antibodies Blunted During Pollen Season
August 27, 2007 -- IRVINE, Calif. -- Cobalis Corp. (OTCBB:CLSC), a pharmaceutical company specializing in anti-allergy medications, today reported that seasonal allergy...
Business Wire - Cobalis Reports PreHistin Demonstrates Significant Potential for Treatment of Vitamin B12 Deficiency
August 2, 2007 -- B12 Levels Increased an Average of More Than 250% Across Two PreHistin-Treated Patient Groups IRVINE, Calif. -- Cobalis Corp. (OTCBB:CLSC), a...
Business Wire - Cobalis Reports Phase III Trial Results for PreHistin™ in Seasonal Allergic Rhinitis
July 6, 2007 -- Low Symptom Levels in Overall Patient Population Lead to Inconclusive Outcome IRVINE, Calif. -- Cobalis Corp. (OTCBB:CLSC), a pharmaceutical...
Journal of Family Practice - [B.sub.12] deficiency: a look beyond pernicious anemia: food-[B.sub.12] malabsorption—not pernicious anemia—is the leading cause of [B.sub.12]...
July 1, 2007 -- Practice recommendations * Mild, preclinical [B.sub.12] deficiency is associated with food-[B.sub.12] malabsorption more often than with pernicious...
Business Wire - Cobalis Announces Delay in Reporting of Phase III Trial Results for PreHistin™ in Seasonal Allergic Rhinitis
May 31, 2007 -- IRVINE, Calif. -- Cobalis Corp. (OTCBB:CLSC), a pharmaceutical development company specializing in anti-allergy medications, today announced that it...
